RMI Partners

RMI Partners is VC firm focused on breakthrough developments of pharmaceutical products and technologies based in the U.S. and Russia.

Be the first to review

Independent rating of RMI Partners VC fund

Overall rating:
Not reviewed

About RMI Partners VC fund

Website:
http://rmivc.com
Founded:
2012
Number of investments:
29
Number of exits:
9
Headquarters:
Moscow, Russian Federation
Organization type:
Venture Capital

How RMI Partners VC fund invests

Rounds:
Series D, Series C, Convertible Note, Series E, Funding Round
Average ticket size:
9.41M USD
Biggest investment:
22.9M USD
Would lead round:
Yes
Would coinvest:
Yes
Countries where invested:
United States
Sectors of interest:
Biotechnology, Health Care, Medical Device, Therapeutics, Pharmaceutical, Health Diagnostics, Mobile, Medical, Hospital, Clinical Trials, Biopharma

Portfolio - latest investments by RMI Partners VC fund
NovaDigm Therapeutics
Binx Health
Celtaxsys
Epic Sciences
Clearside Biomedical
Adastra Pharmaceuticals
Syndax Pharmaceuticals

Founders' reviews of RMI Partners VC fund

Be the first one to review RMI Partners.
Nobody reviews RMI Partners just yet. Help other founders navigate by writing about your experience with them.
Similar funds